Kairos Pharma, Ltd. (KAPA)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $1.38M
Last updated: Nov 17, 2026 at 4:10 PM ET
Kairos Pharma, Ltd. (KAPA) Stock Chart
Kairos Pharma (KAPA) has a latest price of $0.39 on Nov 17, 2026. Its price fell 93.2% over the past 12 months.
Price Chart
From Sep 2024 to Oct 2026, its highest month-end close was $10.99 in Sep 2024 and its lowest $0.53 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KAPA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KAPA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 81.8%, and over 6 months it fell 88.2%.
| Period | Change |
|---|---|
| 1 month | -30.9% |
| 3 months | -81.8% |
| 6 months | -88.2% |
| 12 months | -93.2% |
| 12 months, with dividends | -93.2% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.53 | -89.3% |
| 2025 | $4.97 | -53.3% |
Trading Range
The price is 61.5% below its 50-day average of $1.02 and 85.7% below its 200-day average of $2.75.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.39 | |
| 50-day average | $1.02 | -61.5% |
| 200-day average | $2.75 | -85.7% |
Price Risk
Over 3 years, its largest fall from a peak was 97.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.57 |
| Largest fall, 1 year | -94.2% |
| Largest fall, 3 years | -97.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KAPA
What is KAPA's 1-year price change?
Kairos Pharma's price fell 93.2% over the past 12 months. With dividends included, the 12-month total return was -93.2%.
What is KAPA's beta?
Kairos Pharma's 1-year beta against the S&P 500 is 1.57, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 94.2%.
Is the KAPA chart free?
Yes. Advanced Charting for KAPA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KAPA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors